Fundamentals of Transplant and Cellular Therapy-Day 2 - BiTE therapies - Enduring Material - Credit offering period June 16, 2026 - December 31, 2026
Sophia Marchinko PA-C
*Scientific basis/Immuno-effector cells
References:
NCCN Guidelines, JNCCN Consensus Recommendations, StatPearls
Target Audience
Physicians, nurses, pharmacists, and allied health care professionals who practice in hematological-medical units, skilled nursing facilities, home care, hospice, radiation oncology, surgical oncology, and/or cellular transplant.
Learning Objectives
Discuss the different types of BiTE Therapies
Evaluate the scientific basis of BiTE Therapy
Course summary
- 0.25 AMA PRA Category 1 Credit™
Allegheny General Hospital is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians
Allegheny General Hospital designates this enduring material for a maximum of .25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in this activity.
Available Credit
- 0.25 AMA PRA Category 1 Credit™

Facebook
X
LinkedIn
Forward